FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
Report: Polypharmacy climbed among older adults from 1999 to 2020
By
Kristen Fischer
Jul 02, 2024
The number of older Americans over the age of 65 not living in healthcare facilities who used prescription medications rose from 1999 through the mid-2000s and hasn’t changed much since. The percentage...
Amazon expands mail-order subscriptions to Prime members on Medicare
By
Kristen Fischer
Jun 19, 2024
Amazon.com is letting Prime members on Medicare join its RxPass mail-order prescription service for just $5 a month. The move could save older adults more money on out-of-pocket costs for generic prescription...
First-ever drug can treat ‘bad cholesterol’ that statins miss
By
Kristen Fischer
Aug 29, 2023
A new drug called muvalaplin successfully lowers a genetic form of cholesterol that’s linked to higher risks of strokes and heart attacks, according to a new study published Monday in JAMA. It’s the...
NAMS updates guidance for managing osteoporosis in older women
By
Alicia Lasek
Sep 07, 2021
Lifelong treatment is required to keep osteoporosis under control in post-menopausal women, and hormone therapy is often the best choice to prevent further bone loss, according to the North American Menopause...
FDA: Do not use Dr. Berne’s and LightEyez Eye Drops due to bacteria, fungus
Aug 23, 2023
(HealthDay News) — The U.S. Food and Drug Administration on Tuesday advised people to avoid purchasing and immediately stop using Dr. Berne’s MSM Drops 5 percent Solution and LightEyez MSM...
Eye drop corrects late-life vision loss in trial; Allergan reports patients’ feedback
By
Alicia Lasek
May 10, 2021
Trial participants reported significant near-vision improvements under low-light conditions — without losing distance vision, reports Allergan, which is seeking FDA approval for the drug.
Hypertension drug does not pose health risks, study finds
By
John Roszkowski
Oct 13, 2023
New research suggests that a drug commonly used to treat hypertension is not dangerous, despite the concerns of some clinicians and researchers about potential health risks.
Medical experts devise list of low-value drugs, prescribing practices
By
Caroline Szachnowski
Feb 22, 2022
Researchers have proposed a new metric for identifying low-value medication prescribing in older adults, according to a recent article in JAMA Network Open.
Two Janssen workers push back on anticoagulant recommendation updates
By
Kristen Fischer
Sep 27, 2023
Many older adults take anticoagulants to manage a variety of conditions. But new guidance on how to use them has caused some controversy because it changed some wording. It said certain medications should...